FindTrial
Sign In

Studies on Anticoagulation Therapy After Valve Replacement In Cardiac Patients

Studies on Prothrombin time (PT) and international normalized ratio (INR) for Anticoagulation therapy after valve Replacement.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/06/043174
Enrollment
50
Registered
2022-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I348- Other nonrheumatic mitral valve disorders

Interventions

Intervention1: NIL: NIL

Sponsors

Juno Angel J
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of 18 years and above. 2. All patients with single and double mechanical valve replacement will be enrolled. 3. Patients willing to sign their informed consent form will be included in the study.

Exclusion criteria

Exclusion criteria: 1. Any patients with severe heart failure or renal impairments 2. Patients with any malignancy 3. Child bearing potential population will be excluded. 4. Active or latent Hepatitis B or active Hepatitis C 5. Serious co morbidities such as HIV, Tuberculosis etc. 6. Psychiatric illness 7. Patients who deny giving informed Consent

Design outcomes

Primary

MeasureTime frame
The percentage in reduction of MACE events, cardiovascular events, Thromboembolic accidents/ bleeding eventsTimepoint: At Discharge, 3 Months,9 Months and 12 Months.—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactJuno Angel

VISTAS

suganthi.sls@velsuniv.ac.in9566219596

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026